Expression of CD40 and CD192 in Classical Monocytes in Multiple Sclerosis Patients Assessed with Transcranial Magnetic Stimulation
Expression of CD40 and CD192 markers in different monocyte subpopulations has been
reported to be altered in people with MS (pwMS). Also, functional connectivity of the …
reported to be altered in people with MS (pwMS). Also, functional connectivity of the …
Multiple sclerosis therapies: molecular mechanisms and future
P Fontoura, H Garren - Molecular Basis of Multiple Sclerosis: The Immune …, 2010 - Springer
The current treatments for multiple sclerosis (MS) are, by many measures, not satisfactory.
The original interferon-β therapies were not necessarily based on an extensive knowledge …
The original interferon-β therapies were not necessarily based on an extensive knowledge …
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features
LH Verhey, M Shroff, B Banwell - Neuroimaging …, 2013 - neuroimaging.theclinics.com
Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the
central nervous system (CNS), characterized by immunemediated inflammation and …
central nervous system (CNS), characterized by immunemediated inflammation and …
Emerging multiple sclerosis disease-modifying therapies
PS Giacomini, PJ Darlington… - Current opinion in …, 2009 - journals.lww.com
Several of the emerging therapies focusing on immune-mediated disease mechanisms
seem to offer stronger efficacy than the currently approved immune modulators for MS …
seem to offer stronger efficacy than the currently approved immune modulators for MS …
[PDF][PDF] Cytokines in multiple sclerosis–possible targets for immune therapies
A Trenova, G Slavov - J. Neurol Exp. Neurosci, 2016 - Citeseer
The complex interactions between the central nervous system and the immune system are
mainly mediated via synthesis and secretion of cytokines. Disturbance of the fine balance …
mainly mediated via synthesis and secretion of cytokines. Disturbance of the fine balance …
Natural and induced immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis
M Abraham, A Karni, K Mausner-Fainberg, ID Weiss… - Clinical …, 2017 - Elsevier
Th-17 type immune response that occurs in multiple sclerosis (MS) is linked to CCR6-
CCL20 interaction. We confirmed the dependency on CCR6 in EAE development …
CCL20 interaction. We confirmed the dependency on CCR6 in EAE development …
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies
C Gasperini, S Haggiag, S Ruggieri - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous
system (CNS), traditionally considered to be an autoimmune disease. Despite the standard …
system (CNS), traditionally considered to be an autoimmune disease. Despite the standard …
MIP-3β/CCL19 is associated with the intrathecal invasion of mononuclear cells in neuroinflammatory and non-neuroinflammatory CNS diseases in dogs
J Bartels, BG Darrow, SJ Schatzberg, L Bu… - BMC veterinary …, 2014 - Springer
Background Chemokines such as MIP-3β/CCL19 are important factors in the mechanism of
cell migration and pathogenesis of central nervous system (CNS) inflammatory reactions …
cell migration and pathogenesis of central nervous system (CNS) inflammatory reactions …
Therapeutic potential of IL-27 in multiple sclerosis?
DC Fitzgerald, A Rostami - Expert opinion on biological therapy, 2009 - Taylor & Francis
Background: Multiple sclerosis (MS) is a debilitating neurological disease, characterized by
inflammatory demyelination and axonal degeneration in the CNS. Currently approved …
inflammatory demyelination and axonal degeneration in the CNS. Currently approved …
Chronic cerebrospinal venous insufficiency in multiple sclerosis: A sonographer-blinded case-control study
D Imperiale, F Melis, C Giaccone, M Guido… - Clinical Neurology and …, 2013 - Elsevier
Objectives To evaluate the presence of chronic cerebrospinal venous insufficiency (CCSVI)
and cerebral venous anomalies in a consecutive series of patients with multiple sclerosis …
and cerebral venous anomalies in a consecutive series of patients with multiple sclerosis …